Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A | 0 | uM | 8 | 156.25 | 23.19 | 192.00 | 336.25 | 0.5710 | 0.7296 | |
| MCF 10A | 0 | uM | 8 | 156.25 | 23.19 | 304.00 | 336.25 | 0.9041 | 0.9484 | |
| MCF 10A | 0 | uM | 8 | 156.25 | 23.19 | 450.00 | 336.25 | 1.3383 | 1.1569 | |
| MCF 10A | Linsitinib | 19.9526 | uM | 8 | 156.25 | 23.19 | 62.00 | 336.25 | 0.1844 | 0.2904 |
| MCF 10A | Linsitinib | 3.1623 | uM | 8 | 156.25 | 23.19 | 145.00 | 336.25 | 0.4312 | 0.6082 |
| MCF 10A | Lapatinib | 0.0033113 | uM | 8 | 156.25 | 23.19 | 303.00 | 336.25 | 0.9011 | 0.9468 |
| MCF 10A | Erlotinib | 0.0033113 | uM | 8 | 156.25 | 23.19 | 424.00 | 336.25 | 1.2610 | 1.1239 |
| MCF 10A | Linsitinib | 0.1 | uM | 8 | 156.25 | 23.19 | 147.00 | 336.25 | 0.4372 | 0.6140 |
| MCF 10A | Lapatinib | 0.1 | uM | 8 | 156.25 | 23.19 | 525.00 | 336.25 | 1.5613 | 1.2448 |
| MCF 10A | 0 | uM | 8 | 156.25 | 23.19 | 498.00 | 336.25 | 1.4810 | 1.2143 | |
| MCF 10A | 17-AAG | 0.000066069 | uM | 8 | 156.25 | 23.19 | 362.00 | 336.25 | 1.0766 | 1.0386 |
| MCF 10A | 0 | uM | 8 | 156.25 | 23.19 | 399.00 | 336.25 | 1.1866 | 1.0907 | |
| MCF 10A | Linsitinib | 0.01 | uM | 8 | 156.25 | 23.19 | 556.00 | 336.25 | 1.6535 | 1.2785 |
| MCF 10A | 17-AAG | 0.1 | uM | 8 | 156.25 | 23.19 | 66.00 | 336.25 | 0.1963 | 0.3114 |
| MCF 10A | Lapatinib | 0.01 | uM | 8 | 156.25 | 23.19 | 557.00 | 336.25 | 1.6565 | 1.2795 |
| MCF 10A | Lapatinib | 0.31623 | uM | 8 | 156.25 | 23.19 | 405.00 | 336.25 | 1.2045 | 1.0988 |
| MCF 10A | 17-AAG | 0.31623 | uM | 8 | 156.25 | 23.19 | 66.00 | 336.25 | 0.1963 | 0.3114 |
| MCF 10A | Erlotinib | 0.1 | uM | 8 | 156.25 | 23.19 | 357.00 | 336.25 | 1.0617 | 1.0313 |
| MCF 10A | 0 | uM | 8 | 156.25 | 23.19 | 184.00 | 336.25 | 0.5472 | 0.7107 | |
| MCF 10A | Erlotinib | 19.9526 | uM | 8 | 156.25 | 23.19 | 65.00 | 336.25 | 0.1933 | 0.3063 |
| MCF 10A | Lapatinib | 0.031623 | uM | 8 | 156.25 | 23.19 | 496.00 | 336.25 | 1.4751 | 1.2120 |
| MCF 10A | Lapatinib | 0.0016596 | uM | 8 | 156.25 | 23.19 | 527.00 | 336.25 | 1.5673 | 1.2470 |
| MCF 10A | 17-AAG | 0.031623 | uM | 8 | 156.25 | 23.19 | 38.00 | 336.25 | 0.1130 | 0.1366 |
| MCF 10A | 0 | uM | 8 | 156.25 | 23.19 | 369.00 | 336.25 | 1.0974 | 1.0488 | |
| MCF 10A | 0 | uM | 8 | 156.25 | 23.19 | 197.00 | 336.25 | 0.5859 | 0.7412 |